[
  {
    "ts": null,
    "headline": "Abbott Outpaces Peers Defying Tariff Woes: Is ABT Stock a Smart Buy?",
    "summary": "Despite trade policy challenges, Abbott's global footprint and 90 manufacturing sites offer flexibility to manage regional risks and reroute supply chains.",
    "url": "https://finnhub.io/api/news?id=781b2f3c34405a4122b916a5c26b8f4964ee38efba654686f49cc8824eb44640",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746644400,
      "headline": "Abbott Outpaces Peers Defying Tariff Woes: Is ABT Stock a Smart Buy?",
      "id": 134316773,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Despite trade policy challenges, Abbott's global footprint and 90 manufacturing sites offer flexibility to manage regional risks and reroute supply chains.",
      "url": "https://finnhub.io/api/news?id=781b2f3c34405a4122b916a5c26b8f4964ee38efba654686f49cc8824eb44640"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (ABT) Continued Sixth Straight Quarter of Double-Digit Gains",
    "summary": "Mairs & Power, an investment advisor, released the “Mairs & Power Balanced Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The stock market reached a record high in February. However, tariff uncertainty in March led to a fall in equities, while fixed income benefited from perceived safety. The […]",
    "url": "https://finnhub.io/api/news?id=5696efb23d83ab4041858049654526fc97b3cf79aff4493fc5e1901514535fd7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746625542,
      "headline": "Abbott Laboratories (ABT) Continued Sixth Straight Quarter of Double-Digit Gains",
      "id": 134316774,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Mairs & Power, an investment advisor, released the “Mairs & Power Balanced Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The stock market reached a record high in February. However, tariff uncertainty in March led to a fall in equities, while fixed income benefited from perceived safety. The […]",
      "url": "https://finnhub.io/api/news?id=5696efb23d83ab4041858049654526fc97b3cf79aff4493fc5e1901514535fd7"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "url": "https://finnhub.io/api/news?id=e21a5b23a978960a4e0b24a6c8a6bdd456fbab9ffadc19542c63bcbf2856701b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746622809,
      "headline": "Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It",
      "id": 134316775,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
      "url": "https://finnhub.io/api/news?id=e21a5b23a978960a4e0b24a6c8a6bdd456fbab9ffadc19542c63bcbf2856701b"
    }
  },
  {
    "ts": null,
    "headline": "Abbott and Real Madrid Kick Off Search to Empower Young Soccer Talent",
    "summary": "Abbott (NYSE: ABT) announced today the creation of the inaugural 'Abbott Dream Team.' The program will seek out talented soccer players from across the United States and give them a once-in-a-lifetime opportunity to travel to Madrid where they will showcase their skills and learn from Real Madrid's legendary coaches. Abbott health experts will provide the athletes with the latest advancements in sports health and nutrition to help them gain a deeper understanding of their bodies and achieve peak",
    "url": "https://finnhub.io/api/news?id=4e8dcbe6345d6902bc49c7f674d21f938a02cbbc54b364d8930879eeecac9bad",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746622800,
      "headline": "Abbott and Real Madrid Kick Off Search to Empower Young Soccer Talent",
      "id": 134316776,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott (NYSE: ABT) announced today the creation of the inaugural 'Abbott Dream Team.' The program will seek out talented soccer players from across the United States and give them a once-in-a-lifetime opportunity to travel to Madrid where they will showcase their skills and learn from Real Madrid's legendary coaches. Abbott health experts will provide the athletes with the latest advancements in sports health and nutrition to help them gain a deeper understanding of their bodies and achieve peak",
      "url": "https://finnhub.io/api/news?id=4e8dcbe6345d6902bc49c7f674d21f938a02cbbc54b364d8930879eeecac9bad"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer Predicts Big Earnings for Abbott Laboratories (ABT): Libre Leads the Way!",
    "summary": "We recently published a list of Jim Cramer Talked About These 7 Stocks Recently. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks that Jim Cramer discussed recently. On Monday, Jim Cramer, host of Mad Money, shared valuable insights from his years of experience as […]",
    "url": "https://finnhub.io/api/news?id=1776b5e5194b1ef20e7c151a417850dab1cc1577dab7e7b6b7ce9365bc4306d4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746620065,
      "headline": "Jim Cramer Predicts Big Earnings for Abbott Laboratories (ABT): Libre Leads the Way!",
      "id": 134316777,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "We recently published a list of Jim Cramer Talked About These 7 Stocks Recently. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks that Jim Cramer discussed recently. On Monday, Jim Cramer, host of Mad Money, shared valuable insights from his years of experience as […]",
      "url": "https://finnhub.io/api/news?id=1776b5e5194b1ef20e7c151a417850dab1cc1577dab7e7b6b7ce9365bc4306d4"
    }
  },
  {
    "ts": null,
    "headline": "2024 Total Dividend Income And Portfolio Update",
    "summary": "2024 also saw some changes to some of my holdings as the author shuttled several dividend income payers for higher return crypto plays. Click to read.",
    "url": "https://finnhub.io/api/news?id=e84a491388932db92b15edae67d11240e3b812c212aa814a6209bef6a4a9af74",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746617700,
      "headline": "2024 Total Dividend Income And Portfolio Update",
      "id": 134296532,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2007398242/image_2007398242.jpg?io=getty-c-w1536",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "2024 also saw some changes to some of my holdings as the author shuttled several dividend income payers for higher return crypto plays. Click to read.",
      "url": "https://finnhub.io/api/news?id=e84a491388932db92b15edae67d11240e3b812c212aa814a6209bef6a4a9af74"
    }
  },
  {
    "ts": null,
    "headline": "Impressive Earnings May Not Tell The Whole Story For Abbott Laboratories (NYSE:ABT)",
    "summary": "Abbott Laboratories ( NYSE:ABT ) announced strong profits, but the stock was stagnant. We did some digging, and we...",
    "url": "https://finnhub.io/api/news?id=ad469bcddb34786c9e0cdd4a01bd7acea7d6c1195ed2c78afa58ccebd60492e4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746615109,
      "headline": "Impressive Earnings May Not Tell The Whole Story For Abbott Laboratories (NYSE:ABT)",
      "id": 134316778,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories ( NYSE:ABT ) announced strong profits, but the stock was stagnant. We did some digging, and we...",
      "url": "https://finnhub.io/api/news?id=ad469bcddb34786c9e0cdd4a01bd7acea7d6c1195ed2c78afa58ccebd60492e4"
    }
  },
  {
    "ts": null,
    "headline": "Fidelity Select Health Care Portfolio Q1 2025 Commentary",
    "summary": "For Q1 2025, the Fidelity Select Health Care Portfolio returned -1.03%, underperforming the MSCI health care index. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=6de8cddaa404b5ed7aba0e6986a76a56106ac275d4255bad0da9cb9c149ff259",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746593700,
      "headline": "Fidelity Select Health Care Portfolio Q1 2025 Commentary",
      "id": 134290307,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/91598774/image_91598774.jpg?io=getty-c-w1536",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "For Q1 2025, the Fidelity Select Health Care Portfolio returned -1.03%, underperforming the MSCI health care index. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=6de8cddaa404b5ed7aba0e6986a76a56106ac275d4255bad0da9cb9c149ff259"
    }
  },
  {
    "ts": null,
    "headline": "A Look Back at Medical Devices & Supplies - Diversified Stocks’ Q1 Earnings: Neogen (NASDAQ:NEOG) Vs The Rest Of The Pack",
    "summary": "Wrapping up Q1 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including Neogen (NASDAQ:NEOG) and its peers.",
    "url": "https://finnhub.io/api/news?id=976b08bf680b7961175c00618b05aa3dc1e141c1afdfad1f874ef722a7615f3b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746588713,
      "headline": "A Look Back at Medical Devices & Supplies - Diversified Stocks’ Q1 Earnings: Neogen (NASDAQ:NEOG) Vs The Rest Of The Pack",
      "id": 134290191,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Wrapping up Q1 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including Neogen (NASDAQ:NEOG) and its peers.",
      "url": "https://finnhub.io/api/news?id=976b08bf680b7961175c00618b05aa3dc1e141c1afdfad1f874ef722a7615f3b"
    }
  }
]